Jeremy Grantham will be a keynote speaker at Exchange, joining an exceptional roster of luminaries, thought leaders, and industry titans. Mr. Grantham is a co-founder of GMO, which launched in 1977.
Jeremy Grantham's 13F portfolio value increased from $22.66B to $27.52B this quarter. The largest five stakes in the portfolio are Microsoft Corporation, Alphabet, Meta Platforms, UnitedHealth, and ...
Jeremy Grantham is well-versed in identifying market bubbles, having correctly foreseen the dot-com bubble burst and the 2008 financial crisis. And now, the famed investor has spotted another perilous ...
Legendary market strategist Jeremy Grantham said the U.S. stock market is in a "super bubble", ranking it the third behind ...
Are there any U.S. stocks worth buying right now? Not many, according to Jeremy Grantham, co-founder and chief investment strategist at GMO LLC. In a podcast with Bloomberg that aired Friday, he drops ...
That was the central advice from the investment strategist who earned Wall Street fame for spotting both the dot-com bubble and global financial crisis, Jeremy Grantham, co-founder of the contrarian ...
Jeremy Grantham, the co-founder of GMO and a Wall Street veteran, has identified four areas of the stock market that he believes are worth investing in, despite concerns about a potential bubble. What ...
Jeremy Grantham, co-founder of asset management firm GMO, has issued a warning about a potential “superbubble” in the stock market. Despite current market trends nearing record highs, Grantham advises ...
Bubble-forecasting legend Jeremy Grantham sees plenty of risks in the stock market, but also some opportunities. The investor said in a note on Monday that there are four areas of the stock market he ...
Jeremy Grantham says AI hype has prevented the tech bubble from collapsing. The GMO cofounder is wary of US stocks, real estate, and commodities. Grantham sees a 70% chance of a US recession in the ...
In 2021, Jeremy Grantham was telling anyone who would listen that global asset markets were in one of the biggest bubbles of all time—and that a reckoning was coming. That reckoning, he says, began ...
This article is part of a series that provides an ongoing analysis of the changes made to GMO’s 13F stock portfolio on a quarterly basis. It is based on GMO’s regulatory 13F Form filed on 11/13/2023.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results